BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37273172)

  • 1. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
    Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
    Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Utility of Galactomannan Enzyme Immunoassay in Invasive Aspergillosis in Pediatric patients with Hematological Malignancy.
    Das S; Capoor MR; Singh A; Agarwal Y
    Mycopathologia; 2023 Dec; 188(6):1055-1063. PubMed ID: 37806994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study.
    Jenks JD; Prattes J; Frank J; Spiess B; Mehta SR; Boch T; Buchheidt D; Hoenigl M
    Clin Infect Dis; 2021 Oct; 73(7):e1737-e1744. PubMed ID: 32866234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
    Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
    Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the sōna
    Jani K; McMillen T; Morjaria S; Babady NE
    J Clin Microbiol; 2021 Aug; 59(9):e0059821. PubMed ID: 34232067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
    Serin I; Dogu MH
    Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
    Buil JB; Huygens S; Dunbar A; Schauwvlieghe A; Reynders M; Langerak D; van Dijk K; Bruns A; Haas PJ; Postma DF; Biemond B; Delma FZ; de Kort E; Melchers WJG; Verweij PE; Rijnders B
    J Clin Microbiol; 2023 May; 61(5):e0004423. PubMed ID: 37097150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
    Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
    Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.
    Heng SC; Morrissey O; Chen SC; Thursky K; Manser RL; Nation RL; Kong DC; Slavin M
    Crit Rev Microbiol; 2015 Feb; 41(1):124-34. PubMed ID: 23799871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
    Heldt S; Prattes J; Eigl S; Spiess B; Flick H; Rabensteiner J; Johnson G; Prüller F; Wölfler A; Niedrist T; Boch T; Neumeister P; Strohmaier H; Krause R; Buchheidt D; Hoenigl M
    J Infect; 2018 Sep; 77(3):235-241. PubMed ID: 29972764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis.
    Cao XJ; Li YP; Xie LM; Zhang HL; Qin YS; Guo XG
    Biomed Res Int; 2020; 2020():5434589. PubMed ID: 33335924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
    Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
    Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Aspergillus galactomannan lateral flow assay with a digital reader for the diagnosis of invasive aspergillosis: a multicenter study.
    Guo J; Xiao C; Tian W; Lv L; Hu L; Ni L; Wang D; Li W; Qiao D; Wu W
    Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):249-257. PubMed ID: 38030860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays.
    Guegan H; Robert-Gangneux F; Camus C; Belaz S; Marchand T; Baldeyrou M; Gangneux JP
    J Infect; 2018 Feb; 76(2):196-205. PubMed ID: 29248586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.